Found 79 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years or above
All genders
Phase 3
Interventional
This study investigates the long-term safety and effectiveness of an investigational medication in adults with chronic inflammatory demyelinating polyneuropathy (CIDP). This study is an extension for those who have completed certain previous studies and wish to continue treatment with the investigational medication.Participants in this study will receive weekly doses of …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in adults with moderate to severe Ulcerative Colitis. The study compares different doses of the investigational medication to a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.Participants will be …
16 years - 80 years
All genders
Phase 3
Interventional
The purpose of this study is to investigate the efficacy and safety of an investigational medication in participants with moderately to severely active Ulcerative Colitis (UC). This study includes different arms to evaluate the investigational medication in various scenarios.Participants will undergo procedures such as screening and treatment over several weeks. …
16 years - 80 years
All genders
Phase 3
Interventional
This study investigates the efficacy and safety of an investigational medication in individuals with moderately to severely active ulcerative colitis.Participants will be randomly assigned to receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medicine but does not contain any …
6 months - 17 years
All genders
Phase 3
Interventional
This study investigates the pharmacokinetics and safety of an investigational medication in children aged 6 months to under 18 years who have prurigo nodularis. This study aims to understand how the investigational medication is processed in the body and its safety profile.Participants will undergo various procedures, including clinical assessments and …
30 years - 70 years
Accepts healthy volunteer
All genders
This study investigates the interactions of markers of type 2 diabetes and periodontitis. It aims to evaluate immune signatures and clinical biomarkers in populations with or without these conditions. Participants will be divided into subgroups based on their hemoglobin A1c (HbA1c) levels and periodontal disease stages, which helps to understand …
50 years - 90 years
All genders
Phase 1/2
Interventional
This study investigates the safety and effectiveness of a one-time intravitreal dose of an investigational medication in adults with neovascular age-related macular degeneration (nAMD). The study is conducted in two parts: Part I involves evaluating different dose levels in successive groups of participants, while Part II involves randomizing participants to …
All genders
Phase 2
Interventional
This study investigates the long-term safety and effectiveness of an investigational medication in adults with chronic rhinosinusitis with nasal polyps (CRSwNP). Participants in this study have previously completed a related study and are continuing to evaluate the investigational medication's impact over an extended period.Participants in this study will continue to …
18 years - 55 years
Accepts healthy volunteer
All genders
Phase 1
This study investigates the bioequivalence, which means comparing the effects, of an investigational medication delivered by two different devices in healthy adults. The purpose is to see if the medication works the same way when given through these devices. Participants will receive different doses of the medication, which is given …
18 years or above
All genders
Phase 2
Interventional
This study investigates a treatment for moderate to severe hidradenitis suppurativa (HS), focusing on evaluating the safety and effectiveness of different doses of an investigational medication in participants with this condition.Participants in the study will be randomly assigned to receive either the investigational medication or a placebo, which is an …